Liquidia vs MannKind
LQDA and MNKD side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LQDA and MNKD compare
Liquidia is the larger company, worth 3.9 times as much as MannKind ($5.1B against $1.3B).
Liquidia grew revenue faster over the last twelve months (798% versus 31.7% for MannKind).
Liquidia keeps more of each dollar of sales as profit, with a net margin of −15.1% compared with −18.1% at MannKind.
Liquidia scores higher on the StockData Score (10 against 6 for MannKind), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LQDA | MNKD |
|---|---|---|
| Size and price | ||
| Market cap | $5.1B | $1.3B |
| Share price | $57.41 | $4.13 |
| Change, 1 year | 103% | −21.3% |
| Change, 5 years | 1248% | −13.1% |
| Beta (5Y) | 0.97 | 1.07 |
| Employees | 216 | 241 |
| StockData Score | ||
| Total score | 10 (better) | 6 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 2 |
| Performance score | 2 | 2 |
| Health score | 6 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 8.3× | 3.2× (better) |
| EV/EBITDA | – | 87.0× |
| P/FCF | 17.6× | – |
| FCF yield | 5.7% (better) | −5.9% |
| Fair value | – | $1.11 |
| Margin of safety | – | −273% |
| Growth | ||
| Revenue growth (TTM) | 798% (better) | 31.7% |
| Revenue growth, 5Y average | 192% (better) | 39.9% |
| Net income growth (TTM) | – | −356% |
| EPS growth (TTM) | – | −330% |
| Profitability | ||
| Gross margin | – | 88.6% |
| Operating margin | −15.6% | −2.9% (better) |
| Net margin | −15.1% (better) | −18.1% |
| FCF margin | 46.8% (better) | −19.0% |
| Financial health | ||
| Interest coverage | – | −0.3× |
| Current ratio | 1.02 | 2.22 (better) |
| Altman Z-score | 3.31 (better) | −4.52 |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 81.1% | 56.7% |
| Held by insiders | 19.5% | 2.5% |
| Insider net buying, 12 months | −$227M | −$2.9M (better) |
| Short interest, % of float | 24.3% | 8.4% |
Go deeper
- LQDA stock overview
- LQDA income statement
- LQDA valuation and score
- MNKD stock overview
- MNKD income statement
- MNKD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.